.eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.. we have let patients down, admits senior northern ireland civil servant ..
.experts say years of cuts to nhs budgets and staff has led to patients waiting longer for chemotherapy and radiotherapy (file pic).
.experts say years of cuts to nhs budgets and staff has led to patients waiting longer for chemotherapy and radiotherapy (file pic).